Our Services
Medical Information
Helpful Resources
Published on: 8/18/2026
Calcium crystal arthritis develops when calcium pyrophosphate or basic calcium phosphate crystals accumulate in cartilage and joint fluid, triggering episodes of sudden swelling, warmth, stiffness, and pain that most often affect the knees, wrists, and shoulders. Risk increases with age and is closely tied to previous joint injury, osteoarthritis, family history, and metabolic conditions such as overactive parathyroid glands, iron overload, low magnesium, and thyroid or kidney disease. Because flares can closely mimic gout, septic arthritis, and rheumatoid arthritis, the underlying reason is rarely obvious without joint fluid analysis, imaging, or blood work, and there are several important factors to consider before assuming a cause. See below to understand more about how these triggers are identified, why some flares recur, and which treatment paths actually help.
If your joint is painful, swollen, or hot right now, mapping your symptoms is the fastest way to know whether this needs same-day care or a routine appointment, so take a free, instant, online symptom check to clarify what may be driving your pain and what step to take next.
Last reviewed for medical accuracy: 08/18/2026
Calcium crystal arthritis is a term for joint pain caused by tiny deposits of calcium salts in cartilage and joint fluid. Two common forms are chondrocalcinosis and pseudogout. While many people associate arthritis with wear-and-tear or autoimmune disease, crystal deposits can trigger sudden, severe attacks of joint pain, swelling and stiffness. Understanding why these crystals form—and what to do next—can help you manage symptoms effectively.
Although often lumped together, not everyone with chondrocalcinosis has painful flares. When crystals become dislodged, they can provoke intense inflammation—hence the term pseudogout.
Multiple factors can disrupt the delicate balance of minerals in joint tissues, leading to crystal formation:
Hypophosphatasia is a rare inherited condition marked by low activity of the enzyme alkaline phosphatase. This enzyme helps break down inorganic pyrophosphate (PPi), a natural inhibitor of mineralization. When PPi accumulates in joints, it binds calcium and forms CPPD crystals.
Key points about pseudogout in HPP:
If you have a family history of low alkaline phosphatase, unusual fractures or early-onset joint pain, mention HPP when talking to your doctor.
Crystal arthritis often mimics other joint conditions. Look for:
Because symptoms overlap with septic arthritis and gout, your healthcare provider may recommend:
During a flare of pseudogout or symptomatic chondrocalcinosis:
Always follow dosing recommendations and discuss NSAID risks—especially if you have kidney, liver or cardiovascular concerns.
Preventing future flares and slowing joint damage involves:
Your rheumatologist or primary care provider can tailor a long-term plan, adjusting medications and recommending supportive therapies.
Crystal arthritis flares can be painful but are rarely life-threatening. However, certain signs warrant prompt medical evaluation:
If you’re unsure what’s causing your joint pain—or if you suspect pseudogout in HPP—it may help to do a free, online symptom check, using the doctor approved Ubie Symptom Checker.
Always follow up with your doctor about any new or worsening symptoms. Prompt diagnosis and treatment can reduce pain, preserve joint function and improve quality of life.
This information is intended to help you understand why calcium crystal arthritis occurs, particularly in the context of chondrocalcinosis and pseudogout in HPP. It does not replace personalized medical advice. If you experience severe or persistent joint pain, fever, significant swelling or any symptom that feels serious, speak to a doctor right away.
(References)
* Abhishek A, Tedeschi SK, Pascart T, Latourte A, Dalbeth N, Neogi T, Fuller A, Rosenthal A, Becce F, Bardin T, Ea HK, Filippou G, FitzGerald J, Iagnocco A, Lioté F, McCarthy GM, Ramonda R, Richette P, Sivera F, Andres M, Cipolletta E, Doherty M, Pascual E, Perez-Ruiz F, So A, Jansen TL, Kohler MJ, Stamp LK, Yinh J, Adinolfi A, Arad U, Aung T, Benillouche E, Bortoluzzi A, Dau J, Maningding E, Fang MA, Figus FA, Filippucci E, Haslett J, Janssen M, Kaldas M, Kimoto M, Leamy K, Navarro GM, Sarzi-Puttini P, Scirè C, Silvagni E, Sirotti S, Stack JR, Truong L, Xie C, Yokose C, Hendry AM, Terkeltaub R, Taylor WJ, Choi HK. The 2023 ACR/EULAR Classification Criteria for Calcium Pyrophosphate Deposition Disease. Arthritis Rheumatol. 2023 Oct;75(10):1703-1713. doi: 10.1002/art.42619. Epub 2023 Jul 26. PMID: 37494275; PMCID: PMC10543651.
* Singh N, Vogelgesang SA. Monoarticular Arthritis. Med Clin North Am. 2017 May;101(3):607-613. doi: 10.1016/j.mcna.2016.12.004. Epub 2017 Mar 2. PMID: 28372716.
* Ellis JM. Acute monoarthritis. JAAPA. 2019 Mar;32(3):25-31. doi: 10.1097/01.JAA.0000553379.52389.eb. PMID: 30741851.
* Senthelal S, Li J, Ardeshirzadeh S, Thomas MA. Arthritis. StatPearls. 2026 Jan. PMID: 30085534.
* Haeni D, Müller AM, Tamborrini G. Schulterschmerzen: Was tun bei einer symptomatischen, degenerativen Rotatorenmanschettenruptur? Praxis (Bern 1994). 2017 Feb;106(3):151-153. doi: 10.1024/1661-8157/a002597. PMID: 28169600.
* Azam A, Minalyan A, Naik R. Calcium Pyrophosphate Deposition Disease. StatPearls. 2026 Jan. PMID: 30986010.
* Das SK, Farooqi A. Osteoarthritis. Best Pract Res Clin Rheumatol. 2008 Aug;22(4):657-75. doi: 10.1016/j.berh.2008.07.002. PMID: 18783743.
* Radu L, Groppa L, Vudu L. MUSCULOSKELETAL IMPAIRMENT IN PRYMARY HYPOTHYROIDISM. Rev Med Chir Soc Med Nat Iasi. 2016 Apr-Jun;120(2):244-51. PMID: 27483700.
* Sagarin MJ. Pseudogout. J Emerg Med. 2000 Apr;18(3):373-4. doi: 10.1016/s0736-4679(99)00231-0. PMID: 10729679.
* Abhishek A, Tedeschi SK, Pascart T, Latourte A, Dalbeth N, Neogi T, Fuller A, Rosenthal A, Becce F, Bardin T, Ea HK, Filippou G, Fitzgerald J, Iagnocco A, Lioté F, McCarthy GM, Ramonda R, Richette P, Sivera F, Andrés M, Cipolletta E, Doherty M, Pascual E, Perez-Ruiz F, So A, Jansen TL, Kohler MJ, Stamp LK, Yinh J, Adinolfi A, Arad U, Aung T, Benillouche E, Bortoluzzi A, Dau J, Maningding E, Fang MA, Figus FA, Filippucci E, Haslett J, Janssen M, Kaldas M, Kimoto M, Leamy K, Navarro GM, Sarzi-Puttini P, Scirè C, Silvagni E, Sirotti S, Stack JR, Truong L, Xie C, Yokose C, Hendry AM, Terkeltaub R, Taylor WJ, Choi HK. The 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease. Ann Rheum Dis. 2023 Oct;82(10):1248-1257. doi: 10.1136/ard-2023-224575. Epub 2023 Jul 26. PMID: 37495237; PMCID: PMC10529191.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.